X

Vous n'êtes pas connecté

  - NEWS.MEDICAL.NET - A la Une - 28/Jun 01:31

Targeting mitochondrial dynamics to combat breast cancer metastasis

Breast cancer, particularly triple-negative breast cancer (TNBC), remains a leading cause of cancer-related mortality due to its aggressive nature and limited therapeutic targets.

Articles similaires

Electromagnetic navigation bronchoscopy emerges as an effective alternative for lung nodule localization

news.medical.net - 21/Jun 13:28

Lung cancer remains the leading cause of cancer-related mortality globally. The detection rate of nodules has significantly increased with the...

Electromagnetic navigation bronchoscopy emerges as an effective alternative for lung nodule localization

news.medical.net - 21/Jun 13:28

Lung cancer remains the leading cause of cancer-related mortality globally. The detection rate of nodules has significantly increased with the...

Auckland woman paying $85k for cancer treatment petitions Government for funding

nzherald.co.nz - 27/Jun 01:00

Catherine Cooke petitions Govt to fund Keytruda for early triple negative breast cancer.

Auckland woman paying $85k for cancer treatment petitions Government for funding

nzherald.co.nz - 27/Jun 01:00

Catherine Cooke petitions Govt to fund Keytruda for early triple negative breast cancer.

Rarely studied RNA linked to triple-negative breast cancer

news.medical.net - 01/Jul 07:25

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, it's also one of the most...

IGF2BP1: a critical driver of cancer progression and therapeutic target

oncologynews.com.au - 30/Jun 18:31

The RNA-binding protein IGF2BP1 has emerged as a key regulator of cancer hallmarks, influencing tumour proliferation, metastasis, immune evasion, and...

IGF2BP1: a critical driver of cancer progression and therapeutic target

oncologynews.com.au - 30/Jun 18:31

The RNA-binding protein IGF2BP1 has emerged as a key regulator of cancer hallmarks, influencing tumour proliferation, metastasis, immune evasion, and...

Sorry! Image not available at this time

Melbourne breast cancer trial to test Optiscan imaging device

smh.com.au - 01/Jul 03:46

Optiscan Imaging is recruiting patients into a Melbourne trial of its innovative precision surgery and pathology devices to improve breast cancer...

Optiscan begins breast cancer study in Melbourne

stockhead.com.au - 01/Jul 01:40

Optiscan’s latest study is now underway, using its InVue and InForm devices to help surgeons assess breast cancer margins in ...

Inflammatory Mediators: Key Players in Postmenopausal Breast Cancer

medindia.net - 23/Jun 07:09

Inflammatory mediators like cytokines and chemokines play a key role in driving age-related and postmenopausal breast cancer progression and immune...

Les derniers communiqués

  • Aucun élément